Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Danylo Kaminskyy, Anna Kryshchyshyn & Roman Lesyk. (2017) Recent developments with rhodanine as a scaffold for drug discovery. Expert Opinion on Drug Discovery 12:12, pages 1233-1252.
Read now
Read now
Marco Tuccori, Irma Convertino, Maria Teresa Galiulo, Alessandra Marino, Alice Capogrosso-Sansone & Corrado Blandizzi. (2017) Diabetes drugs and the incidence of solid cancers: a survey of the current evidence. Expert Opinion on Drug Safety 16:10, pages 1133-1148.
Read now
Read now
Articles from other publishers (36)
Hazem Elkady, Abdelrahman A. Abuelkhir, Mahmoud Rashed, Mohammed S. Taghour, Mohammed A. Dahab, Hazem A. Mahdy, Alaa Elwan, Hanan A. Al-ghulikah, Eslam B. Elkaeed, Ibrahim M. Ibrahim, Dalal Z. Husein, Ahmed Metwaly & Ibrahim H. Eissa. (2023) New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies. Computational Biology and Chemistry 107, pages 107958.
Crossref
Crossref
Yunsheng Ran, Chujiao Hu, Junzhao Wan, Qian Kang, Ruixian Zhou, Ping Liu, Dan Ma, Jianta Wang & Lei Tang. (2023) Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma. Frontiers in Pharmacology 14.
Crossref
Crossref
Mostafa M. Ghorab, Aiten M. Soliman, Khaled El-Adl & Noura S. Hanafy. (2023) New quinazoline sulfonamide derivatives as potential anticancer agents: Identifying a promising hit with dual EGFR/VEGFR-2 inhibitory and radiosensitizing activity. Bioorganic Chemistry 140, pages 106791.
Crossref
Crossref
Subhendu Adhikari & Amrit Krishna Mitra. (2023) Perspective on acridine: a versatile heterocyclic biologically imperative framework. Journal of the Iranian Chemical Society 20:10, pages 2399-2455.
Crossref
Crossref
Nada A. A. M. Aziz, Riham F. George, Khaled El‐Adl & Walaa R. Mahmoud. (2022) Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations. Archiv der Pharmazie 356:3.
Crossref
Crossref
Joanna Wojciechowska, Wojciech Krajewski, Tomasz Zatoński & Joel Rodriguez-Saldana. 2023. The Diabetes Textbook. The Diabetes Textbook
1041
1060
.
Igor B. Levshin, Alexander Y. Simonov, Sergey N. Lavrenov, Alexey A. Panov, Natalia E. Grammatikova, Alexander A. Alexandrov, Eslam S. M. O. Ghazy, Nikita A. Savin, Peter V. Gorelkin, Alexander S. Erofeev & Vladimir I. Polshakov. (2022) Antifungal Thiazolidines: Synthesis and Biological Evaluation of Mycosidine Congeners. Pharmaceuticals 15:5, pages 563.
Crossref
Crossref
Mohamed A. Abdelgawad, Khaled El-Adl, Sanadelaslam S. A. El-Hddad, Mostafa M. Elhady, Nashwa M. Saleh, Mohamed M. Khalifa, Fathalla Khedr, Mohamed Alswah, AbdElAziz A. Nayl, Mohammed M. Ghoneim & Nour E. A. Abd El-Sattar. (2022) Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists. Pharmaceuticals 15:2, pages 226.
Crossref
Crossref
Nicole Rodrigues Silva, Francisco Isaac Fernandes Gomes, Alexandre Hashimoto Pereira Lopes, Isadora Lopes Cortez, Jéssica Cristina dos Santos, Conceição Elidianne Aníbal Silva, Raphael Mechoulam, Felipe Villela Gomes, Thiago Mattar Cunha & Francisco Silveira Guimarães. (2021) The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPARγ Receptors. Neurotherapeutics 19:1, pages 434-449.
Crossref
Crossref
Khaled El‐Adl, Helmy Sakr, Sanadelaslam S. A. El‐Hddad, Abdel‐Ghany A. El‐Helby, Mohamed Nasser & Hamada S. Abulkhair. (2021) Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors. Archiv der Pharmazie 354:7.
Crossref
Crossref
Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Rezk R. Ayyad, Hazem A. Mahdy, Mohamed Nasser, Hamada S. Abulkhair & Sanadelaslam S. A. El‐Hddad. (2020) Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors. Archiv der Pharmazie 354:2.
Crossref
Crossref
Tae Woo Kim, Da-Won Hong, Joung Whan Park & Sung Hee Hong. (2020) CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells. British Journal of Cancer 123:12, pages 1737-1748.
Crossref
Crossref
Hardik Joshi, Vijay Patil, Kalpana Tilekar, Neha Upadhyay, Vikram Gota & C.S. Ramaa. (2020) Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib. Bioorganic & Medicinal Chemistry Letters 30:23, pages 127561.
Crossref
Crossref
Md Azhar Iqbal, Asif Husain, Ozair Alam, Shah A. Khan, Aftab Ahmad, Md Rafi Haider & Md Aftab Alam. (2020) Design, synthesis, and biological evaluation of imidazopyridine‐linked thiazolidinone as potential anticancer agents. Archiv der Pharmazie 353:10.
Crossref
Crossref
Kalpana Tilekar, Neha Upadhyay, Jessica D. Hess, Lucasantiago Henze Macias, Piotr Mrowka, Renato J. Aguilera, Franz-Josef Meyer-Almes, Cristina V. Iancu, Jun-yong Choe & C.S. Ramaa. (2020) Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential. European Journal of Medicinal Chemistry 202, pages 112603.
Crossref
Crossref
Khaled El-Adl, Abdel-Ghany A. El-Helby, Helmy Sakr, Ibrahim H. Eissa, Sanadelaslam S.A. El-Hddad & Fatma M.I.A. Shoman. (2020) Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme. Bioorganic Chemistry 102, pages 104059.
Crossref
Crossref
Khaled El‐Adl, Helmy Sakr, Mohamed Nasser, Mohamed Alswah & Fatma M. A. Shoman. (2020) 5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations. Archiv der Pharmazie 353:9.
Crossref
Crossref
Jilei Wang, Guiying Wu, Haiping Chu, Zhongyu Wu & Jingyong Sun. (2020) Paeonol Derivatives and Pharmacological Activities: A Review of Recent Progress. Mini-Reviews in Medicinal Chemistry 20:6, pages 466-482.
Crossref
Crossref
Piotr Mrowka & Eliza Glodkowska-Mrowka. (2020) PPARγ Agonists in Combination Cancer Therapies. Current Cancer Drug Targets 20:3, pages 197-215.
Crossref
Crossref
Danica Sabolova, Pavol Kristian & Mária Kozurkova. (2019) Proflavine/acriflavine derivatives with versatile biological activities. Journal of Applied Toxicology 40:1, pages 64-71.
Crossref
Crossref
Harsh Kumar, Aakash Deep & Rakesh Kumar Marwaha. (2019) Chemical Synthesis, Mechanism of Action and Anticancer Potential of Medicinally Important Thiazolidin-2,4-dione Derivatives: A Review. Mini-Reviews in Medicinal Chemistry 19:18, pages 1474-1516.
Crossref
Crossref
Joanna Krajewska, Wojciech Krajewski & Tomasz Zatoński. 2019. The Diabetes Textbook. The Diabetes Textbook
919
937
.
Angelo Cignarelli, Valentina Annamaria Genchi, Irene Caruso, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola & Francesco Giorgino. (2018) Diabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’. Diabetes Research and Clinical Practice 143, pages 378-388.
Crossref
Crossref
Emanuela Anastasi, Tiziana Filardi, Sara Tartaglione, Andrea Lenzi, Antonio Angeloni & Susanna Morano. (2018) Linking type 2 diabetes and gynecological cancer: an introductory overview. Clinical Chemistry and Laboratory Medicine (CCLM) 56:9, pages 1413-1425.
Crossref
Crossref
Kamel Metwally, Harris Pratsinis & Dimitris Kletsas. (2017) Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation. European Journal of Medicinal Chemistry 133, pages 340-350.
Crossref
Crossref
Eman Flefel, Wael El-Sayed, Ashraf Mohamed, Walaa El-Sofany & Hanem Awad. (2017) Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides. Molecules 22:1, pages 170.
Crossref
Crossref
Daniel Savic, Ryne C. Ramaker, Brian S. Roberts, Emma C. Dean, Todd C. Burwell, Sarah K. Meadows, Sara J. Cooper, Michael J. Garabedian, Jason Gertz & Richard M. Myers. (2016) Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation. Genome Medicine 8:1.
Crossref
Crossref
Julia Naidenow, Igor Hrgovic, Monika Doll, Tsige Hailemariam-Jahn, Victoria Lang, Johannes Kleemann, Stefan Kippenberger, Roland Kaufmann, Nadja Zöller & Markus Meissner. (2016) Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells. Journal of Inflammation 13:1.
Crossref
Crossref
Umesh Bhanushali, Saranya Rajendran, Keerthana Sarma, Pushkar Kulkarni, Kiranam Chatti, Suvro Chatterjee & C.S. Ramaa. (2016) 5-Benzylidene-2,4-thiazolidenedione derivatives: Design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2. Bioorganic Chemistry 67, pages 139-147.
Crossref
Crossref
Saoirse Elizabeth O'Sullivan. (2016) An update on PPAR activation by cannabinoids. British Journal of Pharmacology 173:12, pages 1899-1910.
Crossref
Crossref
Chiara Cilibrasi, Valentina Butta, Gabriele Riva & Angela Bentivegna. (2016) Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?. PPAR Research 2016, pages 1-8.
Crossref
Crossref
Ming‐Yue Li, Hui-Ling Yuan, Fanny W. S. Ko, Bin Wu, Xiang Long, Jing Du, Jun Wu, Calvin S. H. Ng, Innes Y. P. Wan, Tony S. K. Mok, David S. C. Hui, Malcolm J. Underwood & George G. Chen. (2015)
Antineoplastic effects of 15(
S
)‐hydroxyeicosatetraenoic acid and 13‐
S
‐hydroxyoctadecadienoic acid in non–small cell lung cancer
. Cancer 121:S17, pages 3130-3145.
Crossref
Crossref
Hoang Anh, Nguyen Cuc, Bui Tai, Pham Yen, Nguyen Nhiem, Do Thao, Nguyen Nam, Chau Van Minh, Phan Van Kiem & Young Kim. (2015) Synthesis of Chromonylthiazolidines and Their Cytotoxicity to Human Cancer Cell Lines. Molecules 20:1, pages 1151-1160.
Crossref
Crossref
Vivek Asati, Debarshi Kar Mahapatra & Sanjay K. Bharti. (2014) Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents. European Journal of Medicinal Chemistry 87, pages 814-833.
Crossref
Crossref
Mario Nava-Villalba & Carmen Aceves. (2014) 6-Iodolactone, key mediator of antitumoral properties of iodine. Prostaglandins & Other Lipid Mediators 112, pages 27-33.
Crossref
Crossref
Matteo Zanardelli, Laura Micheli, Lorenzo Cinci, Paola Failli, Carla Ghelardini & Lorenzo Di Cesare Mannelli. (2014) Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach. PLoS ONE 9:7, pages e102758.
Crossref
Crossref